Gland Pharma receives USFDA tentative approval for Latanoprostene Bunod Ophthalmic Solution

Gland Pharma has received tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024%.